Biogen (BIIB)

Company Ticker Sector | Industry Quality PAR
Biogen BIIB Healthcare | Biotechnology 84 9.4%
Current Price (01/16) $332.03
CAPS Rating (Rate this stock on CAPS) Foolcaps 5
Expected Income Statement
Current Sales 13,327.6
Sales Growth Forecast 6.7%
Net Profit Margin 35.4%
Projected Shares Outstanding 200.00
EPS - Five year Forecast $32.57
Average P/E Ratio 16.0
Projected Average Price $521.06
Price Appreciation (Annualized) 9.4%
Annual Dividend Yield 0.0%
Projected Annual Return 9.4%
Quality
Financial Strength 89 22.1
EPS Stability 81 20.3
Industry Sales Growth Rate 16.0% 5.2
Industry Net Profit Margin 25.5% 17.4
Calculated Quality Rating 65.0
Fool CAPS

Total Players

998 Outperforms
68 Underperforms
 

All-Stars (260)

250 Outperforms (96%)
10 Underperforms
 
Fundamental Data Updated: 01/04/2019

MIPAR 9.8%  
Sweet Spot 14.8% - 19.8%  

Top In Biotechnology

Ticker Quality PAR
JAZZ 97 17.7%
CBPO 76 16.1%
UTHR 78 12.2%
REGN 69 13.8%
BIIB 84 9.4%

Top In Healthcare

Ticker Quality PAR
ALGN 99 18.7%
JAZZ 97 17.7%
MD 84 17.5%
CVS 87 16.6%
LMAT 85 17.2%